Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of California, Irvine
About this trial
This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.
Eligibility criteria
Qualifiers
Current diagnosis of lung cancer with a driver mutation.
Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.)
Able and willing to give informed consent.
Able and willing to complete the screening questionnaire.
Disqualifiers
There are no exclusion criteria for Cohort A.
Age 40 - 80.
Must have a first degree relative (mother, father, sibling, biological child) eligible for Cohort A. Note: Multiple first degree relatives of a Cohort A eligible participant may be approached for participation into the trial.
Smoked < 20 pack years; a. Pack years = numbers of packs per day × number of years smoked; b. One pack year is the equivalent of smoking an average of 20 cigarettes (1 pack) per day for a year.
Trial design
Treatments tested in this trial
- Low Dose CT Scan
Treatment groups
1,753 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov